Jon M. Jurgovan
123 IP cases indexed. Covers patent matters.
Cases Presided Over
123 cases indexed | Page 4 of 5
Nike, Inc. v.SherryWear, LLC
Nike and SherryWear reached a confidential settlement, leading the PTAB to terminate a series of inter partes reviews, including the one covering patent 10,219,551. The termination was entered under 35 U.S.C. §317 after the trials had already been instituted.
Nike, Inc. v.SherryWear, LLC
Nike successfully petitioned to challenge seven claims of SherryWear's patent based on obviousness over prior art references including Spagna and Rose. The Board found a reasonable likelihood of success regarding claim 1, leading to the institution of the IPR.
Nike, Inc. v.SherryWear, LLC
Nike successfully challenged SherryWear's pocketed bra patent (10219551) before the PTAB. The Board found grounds for institution, agreeing with Nike that various claims were obvious over prior art references like Handras and Spagna. This sets a strong precedent against the validity of apparel patents in this niche market.
Nike, Inc. v.SherryWear, LLC
Nike successfully secured institution for all 14 claims of SherryWear's patent, overcoming the Patent Owner's attempt at discretionary denial. The Board found that Nike presented a reasonable likelihood of prevailing on Claim 1 over Barg and Pintor, leading to an IPR trial.
Phison Electronics Corporation v.Vervain, LLC
The PTAB denied Phison Electronics' request to institute a post‑grant review of Vervain's 11,854,612 patent covering mixed‑level NAND flash memory, finding the petitioner had not shown any claim to be unpatentable.
Phison Electronics Corporation v.Vervain, LLC
The PTAB denied Phison Electronics' petition for post‑grant review of Vervain's NAND‑flash storage patent, finding no sufficient evidence of unpatentability under §§ 101, 103, and 112. No claim constructions were required, and the petition was dismissed without instituting a trial.
Google LLC v.Dialect LLC
Google and Dialect reached a settlement, leading the PTAB to terminate IPR2024-00750 after the trial had been instituted. The settlement agreement will be kept confidential per Board order.
Google LLC v.Dialect LLC
Google LLC successfully initiated an IPR challenge against Dialect LLC's patent (9031845) covering natural language speech processing in vehicles. The Board found a reasonable likelihood of prevailing, focusing on obviousness under 35 U.S.C. § 103 using prior art references like Coffman, Julia, and Cooper.
Google LLC v.Dialect LLC
Google LLC's attempt to invalidate Dialect LLC's speech recognition patent via IPR was denied by the PTAB. The Board found that Google failed to demonstrate a reasonable likelihood of success on its unpatentability grounds under 35 U.S.C. §§ 102 and 103. This decision maintains the validity of the '7398209 patent in the context of ongoing district court litigation.
DISH Network L.L.C. et al. v.Entropic Communications, LLC
The PTAB denied the institution of IPR for DISH Network against Entropic Communications, finding that the Petitioner failed to show a reasonable likelihood of prevailing on any ground. The dispute centers on whether specific probe packet techniques in coaxial networks are obvious.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care and DexCom settled their dispute over U.S. Patent 10,709,364 B2, leading the PTAB to terminate the IPR before any merits were decided. The settlement agreement was also designated as confidential business information.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care Inc.'s IPR challenge against DexCom's glucose monitoring patent was instituted by the PTAB. The Board found a reasonable likelihood of success on anticipation and obviousness grounds over prior art reference Gross, despite acknowledging examination complexity. This decision advances Abbott's efforts to invalidate key claims in the medical device space.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care and DexCom settled their dispute over a continuous glucose monitoring patent, leading the PTAB to terminate the IPR by joint request.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care challenged DexCom's CGM patents in an IPR, arguing the claims are obvious over prior art combining Yarger and Love. The Board granted institution after claim construction, finding a reasonable likelihood of unpatentability for at least one claim.
Phison Electronics Corporation v.Vervain, LLC
The PTAB denied Phison's post‑grant review petition against Vervain’s NAND‑flash storage patent, finding the challenger had not shown a more‑likely‑than‑not chance of unpatentability for any of the seven claims.
Phison Electronics Corporation v.Vervain, LLC
The PTAB denied Phison Electronics’ request to institute a post‑grant review of Vervain’s ’612 NAND‑flash memory patent, finding the challenger’s unpatentability arguments unpersuasive.
Motorola Mobility LLC v.Largan Precision Co., Ltd.
Motorola Mobility LLC's IPR challenge against Largan Precision Co., Ltd.'s optical component patent was denied by the PTAB. The Board found that Petitioner failed to demonstrate a reasonable likelihood of success in overcoming obviousness under 35 U.S.C. § 103.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care and DexCom settled their IPR dispute, leading the PTAB to terminate the proceeding. The settlement agreement was deemed confidential business information.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care and DexCom settled their dispute over DexCom’s glucose‑monitoring patent, leading the PTAB to terminate the IPR. The settlement agreement was deemed confidential business information.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care successfully petitioned to institute IPR proceedings against DexCom for patent infringement related to remote patient monitoring and glucose technology. The Board found a reasonable likelihood of prevailing on multiple grounds, specifically finding that prior art combinations rendered key claims obvious under 35 U.S.C. § 103.
Abbott Diabetes Care Inc. et al. v.DexCom, Inc.
Abbott Diabetes Care Inc. successfully petitioned to challenge DexCom's CGM patent (9119528) on grounds of anticipation and obviousness over Brauker. The Board found a reasonable likelihood of unpatentability for the challenged claims, leading to institution.
Comcast Corporation et al. v.Entropic Communications LLC
The PTAB institution decision found that the Petitioner successfully demonstrated unpatentability of numerous claims under 35 U.S.C. § 103. The Board relied heavily on combinations of prior art references, notably Kamieniecki and Konstantinos, to support its findings against the patent owner. This outcome significantly strengthens the petitioner's position in the ongoing litigation.
Comcast Corporation et al. v.Entropic Communications LLC
The IPR concluded that the Petitioner successfully demonstrated claims 1-18 were unpatentable over prior art references based on obviousness (35 U.S.C. § 103). The Board found a clear motivation to combine Kamieniecki and Konstantinos, overcoming the Patent Owner's arguments regarding redesign complexity.
Comcast Corporation et al. v.Entropic Communications LLC
The PTAB found all 82 challenged claims unpatentable by a preponderance of the evidence. The Petitioner successfully argued that Zhang et al. anticipates or renders obvious the claims through various combinations with Reisman, Jackson, and Pandey. Key findings included that Zhang's demultiplexer/selector satisfies the DFE limitation, and 'concurrently' does not require zero delay.
Comcast Corporation et al. v.Entropic Communications LLC
The PTAB issued a Final Written Decision finding all 20 claims of U.S. Patent No. 9,210,362 unpatentable. The Petitioner successfully demonstrated that the patent was anticipated or obvious over prior art references, primarily Zhang et al., in combination with other cited references.
Comcast Corporation et al. v.Entropic Communications LLC
Comcast’s rehearing request was partially granted: the PTAB corrected a misstatement in claim 4 but upheld the unpatentability of all 24 challenged claims of Entropic’s broadband OFDMA probe patent.
Cox Communications, Inc. v.Entropic Communications LLC
Cox Communications' IPR challenge against Entropic Communications regarding network monitoring technology was denied by the PTAB. The Board found insufficient evidence to establish a reasonable likelihood of prevailing on grounds of obviousness over various prior art references.
Comcast Corporation et al. v.Entropic Communications LLC
The PTAB denied institution for Comcast's IPR against Entropic, finding insufficient evidence that prior art references (Saey and Gross) disclosed or suggested the claimed composite SNR-related metric. This decision reinforces the burden on petitioners to demonstrate specific support for key limitations in complex technical claims.
Comcast Corporation et al. v.Entropic Communications LLC
Comcast Cable Communications successfully argued that multiple claims in the patent were obvious under 35 U.S.C. § 103, leading to an institution decision by the PTAB. The Board found a reasonable likelihood of prevailing on the assertions of obviousness across various combinations of prior art references.
Comcast Corporation et al. v.Entropic Communications LLC
Comcast Cable Communications successfully secured institution in its IPR challenge against the '690 patent, arguing that various prior art references anticipate or render obvious claims related to channel assessment probes. The Board found a reasonable likelihood of unpatentability for certain claims under 35 U.S.C. § 103, leading to the scheduling of trial.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.